Role of m6A writers, erasers and readers in cancer
- PMID: 35945641
- PMCID: PMC9361621
- DOI: 10.1186/s40164-022-00298-7
Role of m6A writers, erasers and readers in cancer
Abstract
The N(6)-methyladenosine (m6A) modification is the most pervasive modification of human RNAs. In recent years, an increasing number of studies have suggested that m6A likely plays important roles in cancers. Many studies have demonstrated that m6A is involved in the biological functions of cancer cells, such as proliferation, invasion, metastasis, and drug resistance. In addition, m6A is closely related to the prognosis of cancer patients. In this review, we highlight recent advances in understanding the function of m6A in various cancers. We emphasize the importance of m6A to cancer progression and look forward to describe future research directions.
Keywords: Cancer; Erasers; N6-methyladenosine (m6A); Readers; Writers.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures


Similar articles
-
Link Between m6A Modification and Cancers.Front Bioeng Biotechnol. 2018 Jul 13;6:89. doi: 10.3389/fbioe.2018.00089. eCollection 2018. Front Bioeng Biotechnol. 2018. PMID: 30062093 Free PMC article. Review.
-
Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers.Front Oncol. 2021 Apr 13;11:635329. doi: 10.3389/fonc.2021.635329. eCollection 2021. Front Oncol. 2021. PMID: 33928028 Free PMC article. Review.
-
Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer.Mol Ther Nucleic Acids. 2022 Jan 21;27:947-955. doi: 10.1016/j.omtn.2022.01.013. eCollection 2022 Mar 8. Mol Ther Nucleic Acids. 2022. PMID: 35211355 Free PMC article. Review.
-
The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer.Front Oncol. 2022 Jul 22;12:927640. doi: 10.3389/fonc.2022.927640. eCollection 2022. Front Oncol. 2022. PMID: 35936737 Free PMC article. Review.
-
The role of N6-methyladenosine modification in tumor angiogenesis.Front Oncol. 2024 Dec 3;14:1467850. doi: 10.3389/fonc.2024.1467850. eCollection 2024. Front Oncol. 2024. PMID: 39691597 Free PMC article. Review.
Cited by
-
Transcriptome-wide N6-methyladenosine modification profiling of long non-coding RNAs in patients with recurrent implantation failure.BMC Med Genomics. 2024 Oct 11;17(1):251. doi: 10.1186/s12920-024-02013-3. BMC Med Genomics. 2024. PMID: 39394578 Free PMC article.
-
POP1 Facilitates Proliferation in Triple-Negative Breast Cancer via m6A-Dependent Degradation of CDKN1A mRNA.Research (Wash D C). 2024 Sep 12;7:0472. doi: 10.34133/research.0472. eCollection 2024. Research (Wash D C). 2024. PMID: 39268503 Free PMC article.
-
Examining the evidence for mutual modulation between m6A modification and circular RNAs: current knowledge and future prospects.J Exp Clin Cancer Res. 2024 Aug 3;43(1):216. doi: 10.1186/s13046-024-03136-2. J Exp Clin Cancer Res. 2024. PMID: 39095902 Free PMC article. Review.
-
Emerging roles of interactions between ncRNAs and other epigenetic modifications in breast cancer.Front Oncol. 2023 Oct 12;13:1264090. doi: 10.3389/fonc.2023.1264090. eCollection 2023. Front Oncol. 2023. PMID: 37901333 Free PMC article. Review.
-
METTL3 promotes immature dental pulp stem cells-induced angiogenesis by regulating ETS1 mRNA stability in an m6A-HuR-dependent manner.Odontology. 2025 Jan;113(1):305-317. doi: 10.1007/s10266-024-00977-3. Epub 2024 Jul 5. Odontology. 2025. PMID: 38969870
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources